IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 256 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $83,000 | -63.3% | 8,616 | +77.0% | 0.01% | 0.0% |
| Q4 2020 | $226,000 | +41.2% | 4,869 | 0.0% | 0.01% | +25.0% |
| Q3 2020 | $160,000 | -70.3% | 4,869 | -75.2% | 0.00% | -66.7% |
| Q2 2020 | $539,000 | -10.5% | 19,627 | -2.5% | 0.01% | -14.3% |
| Q1 2020 | $602,000 | -14.6% | 20,121 | -21.0% | 0.01% | -12.5% |
| Q4 2019 | $705,000 | +95.8% | 25,473 | -32.7% | 0.02% | +100.0% |
| Q1 2019 | $360,000 | +7.5% | 37,870 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $335,000 | +6.7% | 37,870 | +35.6% | 0.01% | +14.3% |
| Q3 2018 | $314,000 | – | 27,937 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |